Regencell Bioscience Holdings (RGC) Current Assets (2020 - 2025)

Regencell Bioscience Holdings' Current Assets history runs 6 years deep, the most recent figure standing at $2.4 million for Q4 2025.

• Quarterly Current Assets changed N/A year-over-year to $2.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.4 million (changed N/A YoY) and the FY2025 annual result came in at $4.9 million, up 1612.29% from the prior year.
• Current Assets was $2.4 million for Q4 2025 at Regencell Bioscience Holdings, down from $4.9 million in the prior quarter.
• Across five years, Current Assets topped out at $11.6 million in Q2 2023 and bottomed at -$1.6 million in Q2 2022.
• A 5-year average of $2.8 million and a median of $1.0 million in 2021 frame the typical range for Current Assets.
• Annual changes were most pronounced in 2022 — Current Assets tumbled 476.07% — and 2025, when it jumped 1612.29%.
• Regencell Bioscience Holdings' Current Assets stood at -$273285.0 in 2021, then tumbled by 476.07% to -$1.6 million in 2022, then surged by 838.18% to $11.6 million in 2023, then plunged by 102.79% to -$324198.0 in 2024, then jumped by 827.09% to $2.4 million in 2025.
• Business Quant data shows RGC's Current Assets at $2.4 million in Q4 2025, $4.9 million in Q2 2025, and -$324198.0 in Q2 2024.